- Puławska 38, 05-500 Piaseczno
- +48 792 850 530
- contact@neo-vinci.com
Randomization is conducted within a single form, without the need to log into an external platform. Any type of randomization can be programmed according to the Sponsor’s requirements and tailored to the specific needs of the clinical trial. The randomization and investigational product dispensing process can be completed with a single click.
The Investigational Product Dispensing Module in NEO-CRF is a key component that enables controlled and protocol-compliant management of study drug distribution to patients. It ensures full process transparency, minimizes the risk of errors, and supports regulatory compliance. Drug dispensing within the IWRS can be performed with a single click by assigning a randomization number to the patient, which also serves as the investigational product number. However, if needed, these processes can be separated and handled in individual tabs.
Automatic patient randomization – the system dynamically assigns patients to appropriate study groups based on a predefined randomization algorithm.
Strict control over drug allocation – the IWRS enables precise management of the drug assignment process, reducing the risk of errors and ensuring compliance with the study protocol.
Fast and secure patient registration – the system enables instant data entry and processing, eliminating the need for manual tracking.
Easy real-time data access – investigators and sponsors can monitor study progress and verify randomization status and treatment assignment at any time.
● Fast and secure randomization process,
● One-click randomization and study drug dispensing,
● Support for double-blind, single-blind, and open-label studies,
●Real-time randomization results with immediate investigator alerts.
PL
